Interferons in host defense

Seminars in Liver Disease

Volumn 17, Issue 4, 1997, Pages 287-295

  Foster, Graham R ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Antiviral; JAK; Signal transduction; STAT

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; ERYTHROPOIETIN; HLA ANTIGEN CLASS 1; INTERLEUKIN 2; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; STAT1 PROTEIN;

ANTIVIRAL ACTIVITY; HOST RESISTANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; VIRUS HEPATITIS; VIRUS INHIBITION;

EID: 0030716893     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007205     Document Type: Review

References (81)

1. Rubinstein M, Levy W, Moschera J, et al. Human leukocyte interferon: Isolation and characterisation of several molecular forms. Arch Biochem Biophys 210:307-318, 1981.
2. Payne M, Leadbeater L. The composition of lymphoblastoid interferon (Wellferon). J Interferon Res 10:5263, 1990.
3. Zoon K, Miller D, Bekisz J, et al. Purification and characterisation of multiple components of human lymphoblastoid Interferon alpha. J Biol Chem 267:15210-15216, 1992.
4. Hiscott J, Cantell K, Weissman C Differential expression of human interferon genes. Nucleic Acid Res 12:3727-3746, 1984.
5. Hauptman R, Sweetly P. A novel class of human type I interferons. Nucleic Acid Res 13:4739-4749, 1985.
6. Pestka S, Langer J, Zoon K, et al. Interferons and their actions, Annu Rev Biochem 56:727-777, 1987.
7. Staeheli P. Interferon induced proteins and the anti-viral state. Adv Virus Res 38:147-200, 1990.
8. Mueller U, Steinhoff U, Reis L, et al. Targeted disruption of the murine type 1 interferon receptor gene. Science 264:1918-1921, 1993.
9. Trinchieri G, Perussia B. Immune interferon: A pleitropic lymphokine with multiple effects. Immunol Today 6:131-136, 1985.
10. Chebath J, Benech P, Revel M, et al. Antiviral activity of 2-5A. Nature 330:587-588, 1987.
11. Rysiecki G, Gewert D, Williams B. 2-5A activity J Interferon Res 9:649-657, 1989.
12. Meurs E, Chong K, Galabru T, et al. Molecular cloning and characterisation of the human double stranded RNA activated protein kinase induced by interferon. Cell 30:112-118, 1987.
13. Samuel C Mechanism of interferon action. Phosphorylation of protein synthesis initiation factor cIF-2 in interferon treated cells by a ribosome associated kinase processing site with specificity similar to hemin-regulated rabbit reticulocyte kinase Proc Natl Acad Sci USA 76:600-604, 1979
14. Staeheli P, Haller O, Boll W, et al. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx DNA confers selective resistance to influenza virus. Cell 44:147-158, 1986.
15. Friedman R, Manly S, McMahon M, et al. Transcriptional and posttranscriptional regulation of Interferon induced gene expression in human cells. Cell 38:745-755, 1984
16. Levy D, Larner A, Chaudhuri A, et al. Interferon-stimulated transcription: Isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci USA 83:8929-8933, 1986
17. Revel M, Chebath J. Interferon activated genes. TIBS 11:166-170, 1986.
18. Hayashi Y, Koike K. Interferon inhibits hepatitis B viral replication in a stable expression system of transfected viral DNA. Virology 63:2936-2940, 1989.
19. Blackman M, Morris A. The effect of Interferon treatment of targets on susceptibility to cytotoxic T cell killing: Augmentation of allogeneic killing and virus specific killing relative to vims antigen expression. Immunology 56:451-457, 1985.
20. Harris H, Gill T. Expression of class I transplantation antigens. Transplantation 42:109-117, 1986.
21. Kelly A, Powis S, Glynne R, et al. Second proteosome related gene in the human class II region. Nature 353:667-668, 1991.
22. Trowsdale J, Hanson I, Mockridge I, et al. Sequences encoded in the class II region of the MHC related to the ABC family of transporters. Nature 349:7412-7414, 1990.
23. Pignatelli M, Waters I, Lever A, et al. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology 6:349-353, 1986.
24. Kitajewski J, Schneider R, Safer B, et al. Adenovirus VAI RNA antagonises the antiviral action of interferon by preventing activation of the interferon-indueed eIF-2a kinase Cell 45:195-200, 1986.
25. Black T, Safer B, Hovanessian A, et al. The cellular 68,000 Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: Implications for translation regulation. J Virol 63:2244-2251, 1989.
26. Roy S, Katze M, Parkin N, et al. Control of the interferon in-duced 68 kilodalton protein kinase by the HIV-1 TAT gene product. Science 247:1216-1219, 1990.
27. Foster G, Goldin R, Hay A, et al. Expression of the terminal protein of hepatitis B virus is associated with a failure to respond to interferon therapy. Hepatology 17:757-762, 1993.
28. Foster G, Ackrill A, Goldin R, et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double stranded RNA. Proc Natl Acad Sci USA 88:2888-2892, 1991.
29. Foster G, Goldin R, Hay A, et al. Expression of the terminal protein of hepatitis B virus is associated with a failure to respond to interferon therapy. Hepatology 17:757-762, 1993.
30. Enomoto N, Sato C, Asahina Y, et al. Comparison of full length sequences of interferon sensitive and resistant hepatitis C virus Ib: Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230, 1995.
31. Enomoto N, Sato C. Clinical relevance of hepatitis C virus quasispecies. J Viral Hepatitis 2:267-272, 1995.
32. Lok A. Treatment of chronic hepatitis B. J Viral Hepatitis 1:91-101, 1993.
33. Foster G, Jacyna M, Thomas H. Interferon treatment of hepatitis, in G Griffin (ed). Cytokines in Infection. London, Baillieres. 1994, pp 145-150.
34. Kessler D, Veals S, Fu X, et al IFN alpha regulates nuclear translocation and DNA binding affinity of ISGF3, a multimeric transcriptional transactivator. Genes Dev 4:1753-1765, 1991;
35. Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: Cloning and expression of its cDNA Cell 60:225-234, 1990.
36. Uze G, Lutfalla G, Mogensen K. Alpha and beta interferons and their receptor and their friends and relatives. J Interferon Cytokine Res 15:3-26, 1995.
37. Pellegrini S, John J, Shearer M, et al. Use of a selectable marker regulated by alpha Interferon to obtain mutations in the signalling pathway. Mol Cell Biol 9:4605-4612, 1989.
38. McKendry R, John J, Flavell D, et al. High frequency mutagenesis of human cells and characterisation of a mutant unresponsive to both α and γ interferons. Proc Natl Acad Sci USA 88: 11455-11459, 1991.
39. Velazquez L, Fellous M, Stark G, et al. A protein tyrosine kinase in the Interferon α/β signalling pathway. Cell 70:313-322, 1992.
40. Firmbach-Kraft I, Byers M, Shows T, et al. Tyk2, a prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5:1329-1336, 1990.
41. Wilks A, Harpur A, Kurban R, et al. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinases. Mol Cell Biol 1:2057-2065, 1991.
42. Muller M, Ibelgaufts H, Kerr I. Interferon response pathways - A paradigm for cytokine signalling? J Viral Hepatitis 1:87-103, 1994.
43. Muller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK1 complements defects in interferon-a/b and gamma signal transduction. Nature 366:129-135, 1993.
44. Fu X, Schindler C, Improta T, et al. The proteins of 1SGF3, the transcriptional activator induced by Interferon -α, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 89:7840-7843, 1992.
45. Schindler C, Shuai K, Prezioso V, et al. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-813, 1992.
46. Watling D, Guschin D, Muller M, et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the Interferon gamma signal transduction pathway. Nature 366:166-170, 1993.
47. Shuai K, Schindler C, Prezioso V, et al. Activation of transcription by IFNgamma;: Tyrosine phosphorylation of a 91 kDa DNA binding protein. Science 1808-1812, 1992.
48. Zhong Z, Zilong W, Darnell J. STAT3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and IL-6 Science 264:95-98, 1994.
49. Zhong Z, Wen Z, Darnell J. Stat3 and Stat4: Members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 91:4806-4810, 1994.
50. Wegenka U, Luttickem C, Buschmann J, et al. The interleukin 6 activated acute phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell Biol 14:3186-3196, 1994.
51. Yuan J, Wegenka U, Luttickem C, et al. The signalling pathways of interleukin 6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol 14:1657-1668,1994.
52. Narazaki M, Witthuhn B, Yoshida K, et al. Activation of JAK2 kinase mediated by the interleukin 6 signal transduction transducer gp130. Proc Natl Acad Sci USA 91:2285-2289, 1994.
53. Lamer A, David M, Feldman G, et al. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261: 1730-1733, 1993.
54. Darnell J, Kerr I, Stark G. Jak STAT pathways and transcriptional activation in response to interferons and other extracellular signalling proteins. Science 264:1415-1421, 1994.
55. Leung S, Li X, Stark G. STATs find that hanging together can be stimulating. Science 273:750-751, 1996
56. Meydan N, Grunberger T, Dadi H, et al. Inhibition of acute lymphoblastic leukaemia by a JAK-2 inhibitor. Nature 379:645-648, 1996.
57. Rhodes J, Ivanyi J, Cozens P. Antigen presentation by human monocytes: Effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production using recombinant interferons and corticosteroids. Eur J Immunol 16:370-375, 1986.
58. Ortaldo J, Herbermann R, Harvey C, et al. A species of human Interferon that lacks the ability to boost natural killer cell activity. Proc Natl Acad Sci USA 81:4926-4929, 1984.
59. Sperber S, Gocke D, Haberzettl C, et al. Anti-HIV activity of recombinant and hybrid species of interferon alpha. J Interferon Res 12:363-368, 1992.
60. Foster G, Rodrigues O, Ghouze F, et al. Differential effects of type I interferons. J Interferon Cytokine Res 1996 (in press).
61. Sandhya Rani M, Foster G, Leung S, et al. Characterisation of beta-R1, a gene that is selectively induced by IFN-beta compared with IFN-alpha. J Biol Chem 1996 (in press).
62. Johnston J, Bacon C, Finbloom D, et al. Tyrosine phosphorylation and activation of STAT5, STAT3 and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705-8709, 1995.
63. Witthuhn B, Silvennoinen M, Miura O, et al. A novel Janus kinase is involved in IL-2 and IL-4 signalling in lymphoid and myeloid cells. Nature 370:153-157, 1994.
64. Nagata Y, Todokoro K. Interleukin 3 activates not only JAK2 and STAT5 but also Tyk2, STAT1 and STAT 3. Biochem Biophys Res Commun 221:785-789, 1996.
65. Schindler C, Kashleva H, Pernis A, et al. STF-IL-4. A novel IL-4 induced signal transducing factor. EMBO J 13:1350-1356,1994.
66. Alam R, Pazdrak K, Stafford S, et al The interleukin 5/receptor interaction activates Lyn and JAK2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and JAK-STAT pathways in eosinophils. Int Arch Allergy Appl Immunol 107: 226-227, 1995.
67. Pazdrak K, Stafford S, Alam R. The activation of the Jak-STAT signalling pathway by IL-5 in eosinophils. J Immunol 155:397-402, 1995.
68. Stahl N, Boulton T, Farrugella T, et al. Association and activation of Jak/Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95, 1994.
69. Foxwell B, Beadling C, Guschin D, et al. Interleukin 7 can induce the activation of JAK 1, JAK 3 and STAT 5 proteins in murine T cells. Eur J Immunol 25:3041-3046, 1995.
70. Yan R, Luo H, Darnell J, et al. A JAK STAT pathway regulates wing vein formation in Drosophila. Proc Natl Acad Sci USA 93:5842-5847, 1996.
71. Nicholson S, Oates A, Harpur A, et al. Tyrosine kinase JAK1 is associated with the granulocyte colony stimulating factor receptor and both become tyrosine phosphorylated after receptor activation. Proc Natl Acad Sci USA 91:2985-2988, 1994.
72. Novak U, Harpur A, Paradiso L, et al. Colony stimulating factor 1 induced STAT 1 and STAT 3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. Blood 86:2948-2956, 1995.
73. Boulton T, Stahl N, Yancopoulos G. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostalin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J Biol Chem 269:11648-11655, 1994.
74. Levy J, Schindler C, Raz R, et al. Activation of the JAK STAT signal transduction pathway by oncostatin M cultured human and mouse osteoblastic cells. Endocrinology 137:1159-1165,1996.
75. Leaman D, Pisharody S, Flickinger S, et al. Role of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16:369-375, 1996.
76. Silvennoinen M, Schindler C, Schlessinger J, et al. Ras independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261:1736-1739, 1993.
77. Witthuhn B, Quelle F, Silvennoinen M, et al. Jak2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236, 1993.
78. Han Y, Leaman D, Watling D, et al. Participation of JAK and STAT proteins in growth hormone induced signalling. J Biol Chem 271:5947-5952, 1996.
79. Rui H, Kirken R, Farrar W. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 269:5364-5368, 1994.
80. Miyakawa Y, Oda A, Druker B, et al. Thrombopoietin induces tyrosine phosphorylation of Stat 3 and Stat 5 in human blood platelets Blood 87:439-446, 1996.
81. Gioregetti-Peraldi S, Peyrade F, Baron V, et al. Involvement of Janus kinases in the insulin signalling pathway. Eur J Biochem 234:656-660, 1995.